Work

AB0553 BASELINE DISEASE ACTIVITY AS A PREDICTOR FOR ACHIEVING cDAPSA TREATMENT TARGETS WITH APREMILAST IN DMARD-NAIVE PATIENTS WITH MANIFESTATIONS OF ACTIVE PSORIATIC ARTHRITIS

Year: 2021

Type: conference-abstract

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2021-eular.2224

Authors: P.J. Mease, A. Kavanaugh, A. Ogdie, A.F. Wells, M. Bergman, D.D. Gladman, F. Behrens, Y. Klyachkin, S. Richter, L. Teng, J.S. Smolen

Institutions: University of Washington, Swedish Medical Center, University of California San Diego, University of Pennsylvania, Drexel University, Schroeder Arthritis Institute, Goethe University Frankfurt, Fraunhofer Institute for Translational Medicine and Pharmacology, Amgen (United States), Medical University of Vienna

Language: English

Topic: Spondyloarthritis Studies and Treatments

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3164814009

Cites:

Cited by: 1

Related to: 10